Alnylam Canada ULC is pleased to announce that Health Canada has issued a Notice of Compliance (NOC) authorizing AMVUTTRA® (vutrisiran) for the treatment of cardiomyopathy in adult patients with ...

Alnylam Pharmaceuticals (ALNY) is drawing fresh attention after being added to the Nasdaq 100, a milestone that tends to pull in index driven demand and sharpen focus on the long term RNAi story. See ...

A technical analysis of Alnylam stock, explaining the recent correction, and what investors should expect next.

In this special bonus episode Talking General Practice speaks to consultant nephrologist Dr Shafi Malik about the heightened ...

Shares of Incyte Corp. rallied 3.39% to $98.64 Monday, on what proved to be an all-around grim trading session for the stock ...

As previously reported, Nasdaq announced the results of the annual reconstitution of the Nasdaq-100 Index, which will become effective prior to ...